ECL
55
-2
YUM
43
-6
GT
56
-3
HCP
56
-8
NOV
52
-5
REGN
38
-2
JBHT
56
-3
GOOG
57
-6
VRSN
53
-5
SNA
70
-5
MAR
63
-5
GOOGL
48
-5
RCL
83
-2
EFX
30
-8
URI
60
-6
JNJ
41
3
EBAY
42
-2
PGR
59
-3
EQT
51
-3
PFE
14
-7
ECL
55
-2
YUM
43
-6
GT
56
-3
HCP
56
-8
NOV
52
-5
REGN
38
-2
JBHT
56
-3
GOOG
57
-6
VRSN
53
-5
SNA
70
-5
MAR
63
-5
GOOGL
48
-5
RCL
83
-2
EFX
30
-8
URI
60
-6
JNJ
41
3
EBAY
42
-2
PGR
59
-3
EQT
51
-3
PFE
14
-7
Financhill
Back

enVVeno Medical Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
23

NVNO
enVVeno Medical

Last Price:
3.29
Seasonality Move:
-6.72%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
23
enVVeno Medical (NVNO) is a Sell

Is enVVeno Medical a Buy, Sell or Hold?

  • The current enVVeno Medical [NVNO] share price is $3.28. The Score for NVNO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVNO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NVNO Stock Price Chart

What is enVVeno Medical's stock price today?

  • The enVVeno Medical share price today is $3.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVNO is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

NVNO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 39.99 Sell
Chaikin Money Flow: -38496 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.27 - 3.49) Sell
Bollinger Bands (100): (3.62 - 5.6) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

NVNO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.46 Sell
20-day SMA: 3.42 Sell
50-day SMA: 3.84 Sell
200-day SMA: 4.9 Sell
8-day EMA: 3.42 Sell
20-day EMA: 3.45 Sell
50-day EMA: 3.8 Sell
200-day EMA: 4.57 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

enVVeno Medical Earnings Growth & NVNO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and an increase next year of $0.11 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

enVVeno Medical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):